
Saving Souls: Alzheimer's Outreach
Webinar Begins at 12:00PM and registration is open until 1230PM
Alzheimer’s disease (AD) disproportionately affects certain populations due to social determinants of health, yet most clinicians lack sufficient knowledge of the latest diagnostic tools and disease-modifying therapies that can help mitigate these disparities. This timely activity is designed to address these gaps with real-world, practical approaches for busy clinicians.
Join expert faculty for this live webinar as we explore innovations and clinical guidance that will reshape how you diagnose, manage, and communicate with patients and families affected by AD.
Join by Zoom: https://us02web.zoom.us/j/87901461247
Jointly provided by UK HealthCare CECentral and DKBmed, LLC.
This activity is supported by an educational grant from Lilly.
New and Migrating Users:
CECENTRAL Enrollment & Access Overview
Account Creation Requirements
- All users must create a brand-new account—old system accounts will not transfer over.
- For UK faculty/staff:
- Use LinkBlue Single Sign-On (SSO).
- After logging in, go to My Account → Edit Profile, and be sure to add your PROFESSION along with (if applicable):
- Your state license number
- Any board certifications (click “Add Another” to include multiple).
Enrollment & Learning Activities
- A new process for enrolling in courses and activities is now in place.
- Timing is important—you must enroll within 30 minutes after the session starts; after that, the system closes enrollment.
- Claiming credit: Must be done within 60 days of the activity date. The system won't allow credit claims if done too early, and extensions aren’t available.
Need Help?
- Support Options:
- Email: [email protected]
- Phone: 859-257-5320
- Hours: Monday–Friday, 8:00 AM–4:30 PM EST
Target Audience
Primary care providers, neurologists, geriatricians, nurse practitioners, and other healthcare professionals involved in dementia care.
Learning Objectives
By the end of this session, participants will be able to:
- Describe the variation in AD prevalence across race, gender, and other demographic factors, and explain how social determinants of health contribute to these differences.
- Identify and interpret emerging diagnostic tools (e.g., plasma biomarkers, advanced imaging) that can facilitate earlier and more accurate diagnosis of AD.
- Evaluate the clinical appropriateness of available disease-modifying treatments for AD and formulate patient-specific plans for early intervention.
- Apply best practices for communicating a diagnosis of AD to patients and caregivers, with sensitivity to cultural, emotional, and systemic barriers.
All of the relevant financial relationships listed for these individuals have been mitigated. The material presented in this course represents information obtained from the scientific literature as well as the clinical experiences of the speakers. In some cases, the presentations might include discussion of investigational agents and/or off-label indications for various agents used in clinical practice. Speakers will inform the audience when they are discussing investigational and/or off-label uses. Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
Gregory Jicha, MD, PhD
Frederick Schmitt, PhD
Available Credit
- 1.00 AMA PRA Category 1 Credit™
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
This Live activity is designated for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
- 1.00 ANCC (UK Healthcare CECentral)
In support of improving patient care, UK HealthCare CECentral is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), the American Nurses Credentialing Center (ANCC), and the Association of Social Work Boards (ASWB) to provide continuing education for the healthcare team.
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.00 nursing contact hour(s).
- 1.00 ParticipationUK Healthcare CECentral certifies this activity for 1.00 hour(s) of participation.